Knight Therapeutics Inc. KHTRF
8.31 USD +0.18 (+2.21%)
Nov 5, 2026, 9:38 AM EST
8.31 Day range 8.31
4.11 52-week range 8.31
- YTD
- +91.03%
- 1 year
- +100.72%
- Market cap
- 816.30M
- EPS (ttm)
- 0.11
- P/E ratio
- 75.55
- YTD return
- +91.03%
- 1-year return
- +100.72%
- Volume
- 200
- Avg volume
- 1.95K
- Open
- 8.31
- Previous close
- 8.13
- Day's range
- 8.31 – 8.31
- 52-week range
- 4.11 – 8.31
2Y +4.09 (+101.24%)
News
Knight Therapeutics Q2 Earnings Call Highlights 
Knight Therapeutics Announces Repayment of Revolving Credit Facility 
Knight Therapeutics Announces Launch of TAVALISSE® in Mexico 
Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Brazil 
Knight Therapeutics Inc. (GUD:CA) Q1 2026 Earnings Call Transcript 
Knight Therapeutics Reports First Quarter 2026 Results 
Knight Therapeutics Inc. announces voting results from the Annual General Meeting 
Knight Therapeutics Inc. (GUD:CA) Shareholder/Analyst Call Prepared Remarks Transcript 
Notice of Knight Therapeutics' First Quarter 2026 Results Conference Call 
Knight Therapeutics Inc. (GUD:CA) Q4 2025 Earnings Call Transcript
Your note
Sign in to keep a note on KHTRF — it syncs with the Stock Master app.